Literature DB >> 29261228

Overview of Monoamine Transporters.

Shaili Aggarwal1, Ole V Mortensen1.   

Abstract

The dopamine (DAT), serotonin (SERT), and norepinephrine (NET) transporters, which are collectively referred to as monoamine transporters (MATs), play significant roles in regulating the neuronal response to these neurotransmitters. MATs terminate the action of these neurotransmitters by translocating them from the synaptic space into the presynaptic neurons. These three transmitters are responsible for controlling a number of physiological, emotional, and behavioral functions, with their transporters being the site of action of drugs employed for the treatment of a variety of conditions, including depression, anxiety, ADHD, schizophrenia, and psychostimulant abuse. Provided in this unit is information on the localization and regulation of MATs and the structural components of these proteins most responsible for the translocation process. Also included is a brief description of the evolution of ligands that interact with these transporters, as well as current theories concerning the pharmacological effects of substances that interact with these sites, including the molecular mechanisms of action of uptake inhibitors and allosteric modulators. Data relating to the presence, structure, and functions of allosteric modulators are included as well. The aim of this review is to provide background information on MATs to those who are new to this field, with a focus on the therapeutic potential of compounds that interact with these substrate transport sites. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  allosteric modulators; dopamine; inhibitors; norepinephrine; releasers; serotonin; substrates; transporters

Mesh:

Substances:

Year:  2017        PMID: 29261228      PMCID: PMC5841473          DOI: 10.1002/cpph.32

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  50 in total

1.  The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.

Authors:  Hai-Ying Zhang; Guo-Hua Bi; Hong-Ju Yang; Yi He; Gilbert Xue; Jiajing Cao; Gianluigi Tanda; Eliot L Gardner; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropsychopharmacology       Date:  2017-03-07       Impact factor: 7.853

2.  The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.

Authors:  Lei Shi; Matthias Quick; Yongfang Zhao; Harel Weinstein; Jonathan A Javitch
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

Review 3.  The use of LeuT as a model in elucidating binding sites for substrates and inhibitors in neurotransmitter transporters.

Authors:  Claus J Loland
Journal:  Biochim Biophys Acta       Date:  2014-04-24

4.  X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.

Authors:  Aravind Penmatsa; Kevin H Wang; Eric Gouaux
Journal:  Nat Struct Mol Biol       Date:  2015-05-11       Impact factor: 15.369

Review 5.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

6.  A competitive inhibitor traps LeuT in an open-to-out conformation.

Authors:  Satinder K Singh; Chayne L Piscitelli; Atsuko Yamashita; Eric Gouaux
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

7.  Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C.

Authors:  Manuel Miranda; Christine C Wu; Tatiana Sorkina; Davin R Korstjens; Alexander Sorkin
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

8.  Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals.

Authors:  Leeann H Miner; Sally Schroeter; Randy D Blakely; Susan R Sesack
Journal:  J Comp Neurol       Date:  2003-11-24       Impact factor: 3.215

9.  Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.

Authors:  Satinder K Singh; Atsuko Yamashita; Eric Gouaux
Journal:  Nature       Date:  2007-08-08       Impact factor: 49.962

10.  X-ray structure of dopamine transporter elucidates antidepressant mechanism.

Authors:  Aravind Penmatsa; Kevin H Wang; Eric Gouaux
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  8 in total

Review 1.  Methamphetamine, neurotransmitters and neurodevelopment.

Authors:  B Čechová; R Šlamberová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

2.  Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in Caenorhabditis elegans through Interactions with the Dopamine Transporter DAT-1.

Authors:  Osama Refai; Shaili Aggarwal; Mary Hongying Cheng; Zayna Gichi; Joseph M Salvino; Ivet Bahar; Randy D Blakely; Ole V Mortensen
Journal:  Mol Pharmacol       Date:  2021-12-14       Impact factor: 4.436

3.  The dopamine transporter antiports potassium to increase the uptake of dopamine.

Authors:  Mette Galsgaard Malle; Anne Kathrine Nielsen; Solveig G Schmidt; Søren S-R Bohr; Ciara F Pugh; Jeppe C Nielsen; Ida H Poulsen; Kasper D Rand; Nikos S Hatzakis; Claus J Loland
Journal:  Nat Commun       Date:  2022-05-04       Impact factor: 17.694

4.  A New Method for the Visualization of Living Dopaminergic Neurons and Prospects for Using It to Develop Targeted Drug Delivery to These Cells.

Authors:  Victor Blokhin; Alina V Lavrova; Sergey A Surkov; Eduard R Mingazov; Natalia M Gretskaya; Vladimir V Bezuglov; Michael V Ugrumov
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

5.  Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools.

Authors:  Jasmin N Beaver; Brady L Weber; Matthew T Ford; Anna E Anello; Sarah K Kassis; T Lee Gilman
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

6.  Synthesis of Novel Nicotinic Ligands with Multimodal Action: Targeting Acetylcholine α4β2, Dopamine and Serotonin Transporters.

Authors:  Juan Pablo González-Gutiérrez; Hernán Armando Pessoa-Mahana; Patricio Ernesto Iturriaga-Vásquez; Miguel Iván Reyes-Parada; Nicolas Esteban Guerra-Díaz; Martin Hodar-Salazar; Franco Viscarra; Pablo Paillali; Gabriel Núñez-Vivanco; Marcos Antonio Lorca-Carvajal; Jaime Mella-Raipán; María Carolina Zúñiga
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

Review 7.  Novel Molecular Targets of Antidepressants.

Authors:  Małgorzata Jarończyk; Jarosław Walory
Journal:  Molecules       Date:  2022-01-14       Impact factor: 4.411

8.  Two Lignan Glycosides from Albizia julibrissin Durazz. Noncompetitively Inhibit Serotonin Transporter.

Authors:  Bishan Huang; Hanhe Liu; Yingyao Wu; Chan Li; Qingfa Tang; Yuan-Wei Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.